Linda Halldner

Linda Halldner

Auto-generated profile, based on publicly available information

Linda Halldner

Department of Clinical Sciences, Child and Adolescent Psychiatry, Umeå University, Umeå, Sweden

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PLPaul Lichtenstein
Paul Lichtenstein
LHLinda Halldner
Linda Halldner
JZJohan Zetterqvist
Johan Zetterqvist
ASArvid Sjölander
Arvid Sjölander
ESEva Serlachius
Eva Serlachius
HLHenrik Larsson
Henrik Larsson
Attention deficit–hyperactivity disorder (ADHD) is a common disorder that has been associated with criminal behavior in some studies. Pharmacologic treatment is available for ADHD and may reduce the risk of criminality. Using Swedish national registers, we gathered information on 25,656 patients with a diagnosis of ADHD, their pharmacologic treatment, and subsequent criminal convictions in Sweden from 2006 through 2009. We used stratified Cox regression analyses to compare the rate of criminality while the patients were receiving ADHD medication, as compared with the rate for the same patients while not receiving medication. As compared with nonmedication periods, among patients receiving ADHD medication, there was a significant reduction of 32% in the criminality rate for men (adjusted hazard ratio, 0.68; 95% confidence interval [CI], 0.63 to 0.73) and 41% for women (hazard ratio, 0.59; 95% CI, 0.50 to 0.70). The rate reduction remained between 17% and 46% in sensitivity analyses among men, with factors that included different types of drugs (e.g., stimulant vs. nonstimulant) and outcomes (e.g., type of crime). Among patients with ADHD, rates of criminality were lower during periods when they were receiving ADHD medication. These findings raise the possibility that the use of medication reduces the risk of criminality among patients with ADHD. (Funded by the Swedish Research Council and others.)

9 November 2012 in Twin Research and Human Genetics
Verified
Journal Article
Closed access
PDF file
PMPatrik K. E. Magnusson
Patrik K. E. Magnusson
CACatarina Almqvist
Catarina Almqvist
IRIffat Rahman
Iffat Rahman
AGAndrea Ganna
Andrea Ganna
AVAlexander Viktorin
Alexander Viktorin
PLPaul Lichtenstein
Paul Lichtenstein
The Swedish Twin Registry (STR) today contains more than 194,000 twins and more than 75,000 pairs have zygosity determined by an intra-pair similarity algorithm, DNA, or by being of opposite sex. Of these, approximately 20,000, 25,000, and 30,000 pairs are monozygotic, same-sex dizygotic, and opposite-sex dizygotic pairs, respectively. Since its establishment in the late 1950s, the STR has been an important epidemiological resource for the study of genetic and environmental influences on a multitude of traits, behaviors, and diseases. Following large investments in the collection of biological specimens in the past 10 years we have now established a Swedish twin biobank with DNA from 45,000 twins and blood serum from 15,000 twins, which effectively has also transformed the registry into a powerful resource for molecular studies. We here describe the main projects within which the new collections of both biological samples as well as phenotypic measures have been collected. Coverage by year of birth, zygosity determination, ethnic heterogeneity, and influences of in vitro fertilization are also described.

1 December 2011 in Twin Research and Human Genetics
Verified
Journal Article
Closed access
PDF file
HAHenrik Anckarsäter
Henrik Anckarsäter
SLSebastian Lundström
Sebastian Lundström
LKLinnea Kollberg
Linnea Kollberg
Nóra KerekesNóra Kerekes
Nóra Kerekes
CPCamilla Palm
Camilla Palm
PLPaul Lichtenstein
Paul Lichtenstein
The Child and Adolescent Twin Study in Sweden (CATSS) is an ongoing longitudinal twin study targeting all twins born in Sweden since July 1, 1992. Since 2004, parents of twins are interviewed regarding the children's somatic and mental health and social environment in connection with their 9th or 12th birthdays (CATSS-9/12). By January 2010, 8,610 parental interviews concerning 17,220 twins had been completed, with an overall response rate of 80%. At age 15 (CATSS-15) and 18 (CATSS-18), twins and parents complete questionnaires that, in addition to assessments of somatic and mental health, include measures of personality development and psychosocial adaptation. Twin pairs in CATSS-9/12 with one or both twins screening positive for autism spectrum disorders, attention deficit/hyperactivity disorder, tic disorders, developmental coordination disorder, learning disorders, oppositional defiant disorder, conduct disorder, obsessive–compulsive disorder, and/or eating problems have been followed with in-depth questionnaires on family, social environment and personality, and subsequently by clinical assessments at age 15 together with randomly selected population controls, including 195 clinically assessed twin pairs from the first 2 year cohorts (CATSS-15/DOGSS). This article describes the cohorts and study groups, data collection, and measures used. Prevalences, distributions, heritability estimates, ages at onset, and sex differences of mental health problems in the CATSS-9/12, that were analyzed and found to be overall comparable to those of other clinical and epidemiological studies. The CATSS study has the potential of answering important questions on the etiology of childhood mental health problems and their role in the development of later adjustment problems.

25 October 2013 in Journal of Child Psychology and Psychiatry
Verified
Journal Article
Closed access
PDF file
ZCZheng Chang
Zheng Chang
PLPaul Lichtenstein
Paul Lichtenstein
LHLinda Halldner
Linda Halldner
BDBrian D'ONofrio
Brian D'ONofrio
ESEva Serlachius
Eva Serlachius
HLHenrik Larsson
Henrik Larsson


1 March 2003 in Stroke
Verified
Journal Article
Closed access
PDF file
UAUlrika Ådén
Ulrika Ådén
LHLinda Halldner
Linda Halldner
HLHugo Lagercrantz
Hugo Lagercrantz
IDIshar Dalmau
Ishar Dalmau
CLCatherine Ledent
Catherine Ledent
BFBertil B. Fredholm
Bertil B. Fredholm
Background and Purpose— Cerebral hypoxic ischemia (HI) is an important cause of brain injury in the newborn infant. Adenosine is believed to protect against HI brain damage. However, the roles of the different adenosine receptors are unclear, particularly in young animals. We examined the role of adenosine A2A receptors (A2AR) using 7-day-old A2A knockout (A2AR(−/−)) mice in a model of HI. Methods— HI was induced in 7-day-old CD1 mice by exposure to 8% oxygen for 30 minutes after occlusion of the left common carotid artery. The resulting unilateral focal lesion was evaluated with the use of histopathological scoring and measurements of residual brain areas at 5 days, 3 weeks, and 3 months after HI. Behavioral evaluation of brain injury by locomotor activity, rotarod, and beam-walking test was made 3 weeks and 3 months after HI. Cortical cerebral blood flow, assessed by laser-Doppler flowmetry, and rectal temperature were measured during HI. Results— Reduction in cortical cerebral blood flow during HI and rectal temperature did not differ between wild-type (A2AR(+/+)) and knockout mice. In the A2AR(−/−) animals, brain injury was aggravated compared with wild-type mice. The A2AR(−/−) mice subjected to HI displayed increased forward locomotion and impaired rotarod performance in adulthood compared with A2AR(+/+) mice subjected to HI, whereas beam-walking performance was similarly defective in both groups. Conclusions— These results suggest that, in contrast to the situation in adult animals, A2AR play an important protective role in neonatal HI brain injury.